[Efficacy and compliance of specific immunotherapy in allergic rhinitis].

Objective: To evaluate the efficacy, safety and compliance of specific immunotherapy in allergic rhinitis.

Method: Two hundred and eighty cases with allergic rhinitis were undertaken immunotherapy, and then were observed its symptoms, signs and treatment by graded score.

Result: Total effective rate was 86.8%, 70.4%, 62.5% at 16 week, 6 months and 1 year after treatment. Of 280 patients treated, 74 patients stopped treatment after one year, compliance rate was 73.6%.

Conclusion: Specific immunotherapy is a safe and effective treatment methods for allergic rhinitis and worthy of attention and promotion, while strengthening the health education is needed to improve treatment compliance of patients.